![Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms | Annals of the Rheumatic Diseases Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/75/5/867/F1.large.jpg)
Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms | Annals of the Rheumatic Diseases
![Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment | The Journal of Rheumatology Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/42/3/379/F1.large.jpg)
Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment | The Journal of Rheumatology
![Schematic of the trial design. DMARD disease modifying antirheumatic... | Download Scientific Diagram Schematic of the trial design. DMARD disease modifying antirheumatic... | Download Scientific Diagram](https://www.researchgate.net/publication/293011719/figure/fig1/AS:329964294557697@1455681026519/Schematic-of-the-trial-design-DMARD-disease-modifying-antirheumatic-drugs-ETN.png)
Schematic of the trial design. DMARD disease modifying antirheumatic... | Download Scientific Diagram
![Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis | Rheumatology and Therapy Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis | Rheumatology and Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40744-021-00357-1/MediaObjects/40744_2021_357_Fig3_HTML.png)
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis | Rheumatology and Therapy
![EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs | Annals of the Rheumatic Diseases EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/69/6/964/F1.large.jpg)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs | Annals of the Rheumatic Diseases
![Conventional disease-modifying anti-rheumatic drugs combined with Chinese Herbal Medicines for rheumatoid arthritis: A systematic review and meta-analysis - ScienceDirect Conventional disease-modifying anti-rheumatic drugs combined with Chinese Herbal Medicines for rheumatoid arthritis: A systematic review and meta-analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2225411022000050-ga1.jpg)
Conventional disease-modifying anti-rheumatic drugs combined with Chinese Herbal Medicines for rheumatoid arthritis: A systematic review and meta-analysis - ScienceDirect
![Medicina | Free Full-Text | Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents Medicina | Free Full-Text | Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents](https://www.mdpi.com/medicina/medicina-58-00571/article_deploy/html/images/medicina-58-00571-g003.png)
Medicina | Free Full-Text | Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
![Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13075-019-1893-z/MediaObjects/13075_2019_1893_Fig1_HTML.png)
Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in
![Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis - ScienceDirect Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332222005157-ga1.jpg)
Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis - ScienceDirect
![Biomedicines | Free Full-Text | DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs ( DMARDs) in Rheumatoid Arthritis Biomedicines | Free Full-Text | DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs ( DMARDs) in Rheumatoid Arthritis](https://pub.mdpi-res.com/biomedicines/biomedicines-11-01987/article_deploy/html/images/biomedicines-11-01987-g001-550.jpg?1689326268)
Biomedicines | Free Full-Text | DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs ( DMARDs) in Rheumatoid Arthritis
![Phytochemical add-on therapy to DMARDs therapy in rheumatoid arthritis: In vitro and in vivo bases, clinical evidence and future trends - ScienceDirect Phytochemical add-on therapy to DMARDs therapy in rheumatoid arthritis: In vitro and in vivo bases, clinical evidence and future trends - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661821002024-ga1.jpg)